George Gotzamanis

This inventor holds 8 USPTO granted patents and 3 published patent applications and 9 EPO patents. Top assignee: Pharmathen S.a.. Active years: 2019-2025.

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 9.1

ph-index = 1

Company Filing History:

8 out of 20

Pharmathen S.a.

patents

Years Active: 2019-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458645 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-11-04),

2. 12453732 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-10-28),

3. 11969429 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2024-04-30),

4. 11318114 - Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof (2022-05-03),

5. 11154585 - Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population (2021-10-26),

6. 10772830 - Preservative free pharmaceutical compositions for ophthalmic administration (2020-09-15),

7. 10702471 - Preservative free pharmaceutical compositions for ophthalmic administration (2020-07-07),

8. 10350161 - Preservative free pharmaceutical compositions for ophthalmic administration (2019-07-16),

Title: Innovations by George Gotzamanis

Introduction

George Gotzamanis is a notable inventor based in Pallini Attikis, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of 8 patents to his name, his work has the potential to impact pediatric medicine significantly.

Latest Patents

One of his latest patents is titled "Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof." This innovative powder includes Valaciclovir or a pharmaceutical acceptable salt or derivative thereof, combined with an ion exchange resin. The Valaciclovir is complexed with the ion exchange resin to form Drug-Resin complex (DRC) particles. Each DRC particle comprises hydrogen bonds between the ion exchange resin and a cationic center of Valaciclovir. The ratio of Valaciclovir to the ion exchange resin in the DRC particle is 1:0.5. Additionally, the powder includes a suspending agent and a pH agent, with the suspending agent forming a film around each DRC particle to decrease interparticle attraction. This powder is designed to be reconstituted with an aqueous diluent for oral administration.

Career Highlights

George Gotzamanis has been instrumental in advancing pharmaceutical formulations through his innovative approaches. His work at Pharmathen S.A. has allowed him to focus on developing effective treatments for various medical conditions, particularly in the pediatric field.

Collaborations

He has collaborated with notable coworkers, including Evangelos Karavas and Vasiliki Samara, who have contributed to his research and development efforts.

Conclusion

George Gotzamanis is a prominent inventor whose work in antiviral formulations is paving the way for advancements in pediatric medicine. His innovative patents reflect his commitment to improving healthcare outcomes for children.